Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

(If you have a story in and around Mumbai, you have our ears, be a citizen journalist and send us your story here. )

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Tech layoffs: Google has sacked its mental health team, and it can backfire

Tech layoffs: Google has sacked its mental health team, and it can backfire

Adani fiasco pushes India out of top 5 countries by market capitalisation

Adani fiasco pushes India out of top 5 countries by market capitalisation

Powergrid Corporation of India approves 2nd interim dividend payment of Rs 5 per share

Powergrid Corporation of India approves 2nd interim dividend payment of Rs 5 per share

Earnings 2023 LIVE: Sun Pharma net profit at Rs 2,180.75 cr, Godrej Consumer Products net profit at...

Earnings 2023 LIVE: Sun Pharma net profit at Rs 2,180.75 cr, Godrej Consumer Products net profit at...

Here are PNBs hiked lending rates for all tenors

Here are PNBs hiked lending rates for all tenors